Your browser doesn't support javascript.
loading
Comparison of the clinicopathologic features of prostate cancer in US and Chinese populations.
Zhang, Lei; Liu, Xiaoyan; Xia, Rong; Chen, Fei; Wang, Xin; Bao, Jia; Shao, Yongzhao; Lu, Xian; Wang, Yan; Wang, Jili; Tun, May Thu; Melamed, Jonathan; Lepor, Hebert; Deng, Fang-Ming; Wang, Dongwen; Ren, Guoping.
Afiliación
  • Zhang L; Department of Urology, The First Hospital of Shangxi Medical University, Shanxi, China.
  • Liu X; Department of Pathology, The First Hospital of Zhejiang University, Zhejiang, China.
  • Xia R; Department of Pathology, New York University School of Medicine, New York, NY, USA.
  • Chen F; Department of Pathology, New York University School of Medicine, New York, NY, USA.
  • Wang X; Department of Urology, The First Hospital of Shangxi Medical University, Shanxi, China.
  • Bao J; Division of Biostatistics, New York University School of Medicine, New York, NY, USA.
  • Shao Y; Division of Biostatistics, New York University School of Medicine, New York, NY, USA.
  • Lu X; Department of Urology, The First Hospital of Shangxi Medical University, Shanxi, China.
  • Wang Y; Department of Pathology, The First Hospital of Zhejiang University, Zhejiang, China.
  • Wang J; Department of Pathology, The First Hospital of Zhejiang University, Zhejiang, China.
  • Tun MT; Department of Pathology, New York University School of Medicine, New York, NY, USA.
  • Melamed J; Department of Pathology, New York University School of Medicine, New York, NY, USA.
  • Lepor H; Department of Urology, New York University School of Medicine, New York, NY, USA.
  • Deng FM; Department of Pathology, New York University School of Medicine, New York, NY, USA; Department of Urology, New York University School of Medicine, New York, NY, USA.
  • Wang D; Department of Urology, Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Guang Dong, China.
  • Ren G; Department of Pathology, The First Hospital of Zhejiang University, Zhejiang, China.
Pathol Res Pract ; 234: 153933, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35525175

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Pathol Res Pract Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Pathol Res Pract Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania